Your fact-checks will appear here
The antiviral activity of ivermectin against SARS-CoV-2 in laboratory settings.
Preclinical literature shows repeated, drug‑level interactions between ivermectin and multiple chemotherapy or targeted agents—mostly beneficial pharmacodynamic synergies (enhanced tumor cell kill, re...
Large, well‑designed and subsequent large meta‑analyses have generally failed to find that ivermectin prevents hospitalization, speeds recovery, or reduces mortality from COVID‑19; smaller trials and ...
Federal health agencies warn strongly against using veterinary ivermectin in humans because it is not approved for COVID-19, can be highly concentrated and toxic, and because real‑world signals—rising...